URGN News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2018-02-14 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2018-01-11 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2018-01-08 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-12-14 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-11-14 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-11-07 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-11-02 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-08-29 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-08-14 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-07-19 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |
| 2017-05-18 | Foreign issuer report | SEC filing | UroGen Pharma Ltd. filed Form 6-K | UroGen Pharma Ltd. filed Form 6-K. |